Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulomatous lung diseases

European Respiratory Journal

Volumn 12, Issue 4, 1998, Pages 920-925

  Kunitake, R ^a   Kuwano, K ^a   Miyazaki, H ^a   Kawasaki, M ^a   Hagimoto, N ^a   Fujita, M ^a   Kaneko, Y ^a   Hara, N ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Collagen vascular disease; Fas antigen; Hypersensitivity pneumonitis; p21 (Waf1 Cip1 Sdi1); p53; Sarcoidosis

Indexed keywords

COLLAGEN; DNA; FAS ANTIGEN; PROTEIN P21; PROTEIN P53;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHIOLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS; TRANSBRONCHIAL BIOPSY; VASCULAR DISEASE;

ADULT; AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; ANTIGENS, CD95; BIOPSY, NEEDLE; CULTURE TECHNIQUES; DNA DAMAGE; FEMALE; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY FIBROSIS; REFERENCE VALUES; RHOA GTP-BINDING PROTEIN; SARCOIDOSIS, PULMONARY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0031754484     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12040920     Document Type: Article

References (30)

1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-6311.
2. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-7495.
3. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849.
4. Nelson WG, Kastan MB. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 1994; 14: 1815-1823.
5. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
6. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90-98.
7. El-Deily WS, Takashi T, Veluculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
8. El-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/ CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54: 1169-1174.
9. Itoh N, Yonehara S, Ishii SA, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
10. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
11. Kuwano K, Kunitake R, Kawasaki M, et al. p21 (Waf1/ Cip1) and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154: 477-483.
12. Leithäuser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69: 415-429.
13. Kuwano K, Miyazaki H, Hagimoto N, et al. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 1998; in press.
14. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med 1984; 310: 154-166.
15. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
16. Shin RW, Iwaki T, Kitamoto T, Tatelshi J. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest 1991; 64: 693-702.
17. Antoniades HN, Galanopoulos T, Neville-Golden J, Kiritsy CP, Lynch SE. p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine. J Clin Invest 1994; 93: 2206-2214.
18. WAF1/CIP1/SDI1 and p53 in apoptotic cells in the adrenal cortex and induction by ischemia/reperfusion injury. J Clin Invest 1996; 91: 1723-1731.
19. Guinee D Jr, Fleming M, Hayashi T, et al. Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol 1996; 149: 531-538.
20. Behrmann I, Walczak H, Krammer PH. Structure of the human APO-1 gene. Eur J Immunol 1994; 24: 3057-3062.
21. Chen J, Liu C, Koopman WJ, Mountz JD. Characterization of human Fas gene: exon/intron organization and promoter region. J Immunol 1995; 154: 1239-1245.
22. Owen-Schaub LB, Zliang W, Cusack JC, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/Apo-1 expression. Mol Cell Biol 1995; 15: 3032-3040.
23. Tamura T, Aoyama N, Saya H, et al. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 1995; 11: 1939-1946.
24. Takahashi R. Role of p53 tumor suppressor gene and Fas/ APO-1 in induction of apoptosis and differentiation of cancer cells. Leukemia 1997; 3: 331-333.
25. Müller M, Strand S, Hug H, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/ Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997; 99: 403-413.
26. Hiramatsu N, Hayashi N, Katayama K, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-1359.
27. Kerr JFR, Cooksley WGE, Searle J, et al. The nature of piecemeal necrosis in chronic active hepatitis. Lancet 1979; 2: 827-828.
28. Russell JH. Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunol Rev 1983; 72: 97-118.
29. Takehara T, Hayashi N, Katayama K, et al. Two-dimensional flow cytometric analysis of intrahepatic lymphocytes subsets from patients with chronic hepatitis. Dig Dis Sci 1991; 36: 87-91.
30. Wyllie AH, Karr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 8: 251-306.